Literature DB >> 25726055

Surgical management of pancreatic cancer--pancreaticoduodenectomy.

Timothy R Donahue1, Howard A Reber2.   

Abstract

Pancreaticoduodenectomy, the Whipple resection, is a complex operation that is commonly performed for patients with pancreatic ductal adenocarcinoma and other malignant or benign lesions in the head of the pancreas. It can be done with low morbidity and mortality rates, particularly when performed at high-volume hospitals and by high-volume surgeons. While it has been conventionally reserved for patients with early-stage malignant disease, it is being used increasingly for patients with locally extensive tumors who have undergone neoadjuvant therapy and downstaging. This article summarizes the role of pancreaticoduodenectomy for the treatment of patients with pancreatic cancer. It highlights the surgical staging of disease, the technical aspects of the operation and perioperative care, and the oncologic outcome.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25726055     DOI: 10.1053/j.seminoncol.2014.12.009

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  14 in total

1.  Intestinal autotransplantation for neoplasms originating in the pancreatic head with involvement of the superior mesenteric artery.

Authors:  Guosheng Wu; Xin Wang; Qingchuan Zhao; Weizhong Wang; Hai Shi; Mian Wang; Jingson Zhang; Zengshan Li; Daiming Fan
Journal:  Langenbecks Arch Surg       Date:  2016-04-23       Impact factor: 3.445

2.  How I Do It: Hybrid Laparoscopic and Robotic Pancreaticoduodenectomy.

Authors:  R Matthew Walsh; Sricharan Chalikonda
Journal:  J Gastrointest Surg       Date:  2016-06-06       Impact factor: 3.452

3.  Pancreaticoduodenectomy for pediatric and adolescent pancreatic malignancy: A single-center retrospective analysis.

Authors:  Erika B Lindholm; Abdulaziz K Alkattan; Sara J Abramson; Anita P Price; Todd E Heaton; Vinod P Balachandran; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2016-11-16       Impact factor: 2.545

4.  [Criteria for resectability of pancreatic cancer and postoperative imaging].

Authors:  L Grenacher; M Juchems
Journal:  Radiologe       Date:  2017-12       Impact factor: 0.635

5.  Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer.

Authors:  Joji Watanabe; Shinji Otani; Teruhisa Sakamoto; Yosuke Arai; Takehiko Hanaki; Masataka Amisaki; Naruo Tokuyasu; Soichiro Honjo; Masahide Ikeguchi
Journal:  Surg Today       Date:  2016-02-11       Impact factor: 2.549

6.  The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy.

Authors:  Daniel J Kagedan; Nik Goyert; Qing Li; Lawrence Paszat; Alexander Kiss; Craig C Earle; Paul J Karanicolas; Alice C Wei; Nicole Mittmann; Natalie G Coburn
Journal:  J Gastrointest Surg       Date:  2017-01-05       Impact factor: 3.452

7.  Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients.

Authors:  Sara Krogh; Henning Grønbæk; Anders Riegels Knudsen; Peter Kissmeyer-Nielsen; Nynne Emilie Hummelshøj; Gitte Dam
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

8.  Natural History and Treatment Trends in Pancreatic Cancer Subtypes.

Authors:  Courtney J Pokrzywa; Daniel E Abbott; Kristina A Matkowskyj; Sean M Ronnekleiv-Kelly; Emily R Winslow; Sharon M Weber; Alexander V Fisher
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

Review 9.  Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.

Authors:  Christopher Gromisch; Motaz Qadan; Mariana Albuquerque Machado; Kebin Liu; Yolonda Colson; Mark W Grinstaff
Journal:  Cancer Res       Date:  2020-03-27       Impact factor: 12.701

10.  Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.

Authors:  Su-Jin Shin; Hosub Park; You-Na Sung; Changhoon Yoo; Dae Wook Hwang; Jin-Hong Park; Kyu-Pyo Kim; Sang Soo Lee; Baek-Yeol Ryoo; Dong-Wan Seo; Song Cheol Kim; Seung-Mo Hong
Journal:  Cancer Res Treat       Date:  2017-12-20       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.